Agios Pharmaceuticals, Inc. (AGIO)
33.60
-0.04
(-0.12%)
USD |
NASDAQ |
Sep 11, 16:00
33.59
-0.01
(-0.03%)
After-Hours: 20:00
Agios Pharmaceuticals Total Return Level : 33.60 for Sept. 11, 2026
Total Return Level Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Level Data
| Date | Value |
|---|---|
| September 11, 2026 | 33.60 |
| September 10, 2026 | 33.64 |
| September 09, 2026 | 34.63 |
| September 08, 2026 | 33.55 |
| September 04, 2026 | 33.10 |
| September 03, 2026 | 33.13 |
| September 02, 2026 | 34.13 |
| September 01, 2026 | 34.21 |
| August 31, 2026 | 33.68 |
| August 28, 2026 | 33.32 |
| August 27, 2026 | 34.28 |
| August 26, 2026 | 33.99 |
| August 25, 2026 | 33.90 |
| August 24, 2026 | 32.64 |
| August 21, 2026 | 33.09 |
| August 20, 2026 | 33.63 |
| August 19, 2026 | 35.12 |
| August 18, 2026 | 34.40 |
| August 17, 2026 | 33.63 |
| August 14, 2026 | 33.56 |
| August 13, 2026 | 33.47 |
| August 12, 2026 | 34.21 |
| August 11, 2026 | 32.69 |
| August 10, 2026 | 32.59 |
| August 07, 2026 | 32.27 |
| Date | Value |
|---|---|
| August 06, 2026 | 31.95 |
| August 05, 2026 | 31.72 |
| August 04, 2026 | 31.60 |
| August 03, 2026 | 30.54 |
| July 31, 2026 | 30.02 |
| July 30, 2026 | 32.75 |
| July 29, 2026 | 35.01 |
| July 28, 2026 | 35.99 |
| July 27, 2026 | 36.97 |
| July 24, 2026 | 36.36 |
| July 23, 2026 | 36.28 |
| July 22, 2026 | 36.05 |
| July 21, 2026 | 37.36 |
| July 20, 2026 | 40.06 |
| July 17, 2026 | 39.61 |
| July 16, 2026 | 38.72 |
| July 15, 2026 | 39.87 |
| July 14, 2026 | 39.92 |
| July 13, 2026 | 40.55 |
| July 10, 2026 | 41.23 |
| July 09, 2026 | 42.79 |
| July 08, 2026 | 42.76 |
| July 07, 2026 | 44.01 |
| July 06, 2026 | 37.39 |
| July 02, 2026 | 37.58 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| ACADIA Pharmaceuticals, Inc. | 27.83 |
| Biogen, Inc. | 217.15 |
| Insmed, Inc. | 129.41 |
| Alnylam Pharmaceuticals, Inc. | 248.68 |
| Regeneron Pharmaceuticals, Inc. | 788.74 |